<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00313105</url>
  </required_header>
  <id_info>
    <org_study_id>2005-004626-10</org_study_id>
    <nct_id>NCT00313105</nct_id>
  </id_info>
  <brief_title>Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches</brief_title>
  <official_title>Smoking Cessation by Nurses With Smokeless Tobacco Buccal Tablets, Nicotine Buccal Tablets, Nicotine Patches With Repeated Therapy Every 6 Months for 2 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Research Foundation, FSS, Copenhagen, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test if smokeless tobacco is more effective than nicotine buccal tablets in smoking
      cessation compared with a control group with low dose nicotine patches.

      Also retreatment will be tested with smokeless tobacco every 6 months in failures for 1½
      year. Adherence to the program will be enhanced by assessment of cholesterol, blood pressure,
      lung function and body weight every 6 months for 2 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open randomized controlled trial with 3 groups testing smokeless tobacco in
      smoking cessation: 200 smokers will get smokeless tobacco for 3 months, 200 will get nicotine
      buccal tablets for 3 months and 200 will get 7-mg nicotine patches for 3 months (control
      arm). After ½, 1 and 1½ a year failures will get smokeless tobacco in the first 2 groups,
      while only 7 mg nicotine patches in control group until 1½ year where failures in this group
      also will get smokeless tobacco. Every ½ year cholesterol, blood pressure, lung function and
      BMI will be assessed and used to enhance adherence of the participants in this trial.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2006</start_date>
  <completion_date type="Anticipated">August 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abstinence from smoking after ½ year (point and continuous abstinence)</measure>
    <time_frame>6 months from entry</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events between 3 arms</measure>
    <time_frame>Up to 6 months from entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of inhalation between 3 arms (p-cotinine and p-thiocynate and u-NNAL)</measure>
    <time_frame>3 and 6 months from entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to study</measure>
    <time_frame>6,12,24 months from entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of retreatment (abstinence after 1, 1½ and 2 years)</measure>
    <time_frame>12,18 and 24 months from entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cholesterol, blood-pressure, lung function, body-weight across smoking status</measure>
    <time_frame>6,12,24 months from entry</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Tobacco Dependence</condition>
  <arm_group>
    <arm_group_label>Smokeless Tobacco</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Smokeless Tobacco and individual visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicotine tablets</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nicotine tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>7-mg nicotine patch acts as placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Smokeless tobacco (Oliver Twist pellets)</intervention_name>
    <description>individual visits with counseling</description>
    <arm_group_label>Smokeless Tobacco</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>smoking cessation counseling</intervention_name>
    <description>individual visits</description>
    <arm_group_label>Smokeless Tobacco</arm_group_label>
    <arm_group_label>Nicotine tablets</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  smokers (&gt;7 cig/day)

          -  Healthy

          -  Allowed: treated hypertension, diabetes treated with tablets, increased
             cholesterol,other &quot;mild&quot; diseases

          -  mild asthma and COPD,

          -  Motivated to quit smoking

          -  Motivated to follow the protocol

          -  Motivated to use medication in this trial

        Exclusion Criteria:

          -  Severe diseases

          -  Psychiatric diseases

          -  Used NRT or Zyban the last 2 weeks

          -  Stopped smoking &gt;2 days during last 3 months

          -  More than 6 alcoholic drinks per day

          -  Smokes other products than cigarettes

          -  Pregnant of lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Tønnesen, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chair dept. pulm. medicine, Gentofte Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. pulmonary medicine Y, Gentofte University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hellerup</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2006</study_first_submitted>
  <study_first_submitted_qc>April 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2006</study_first_posted>
  <last_update_submitted>September 14, 2009</last_update_submitted>
  <last_update_submitted_qc>September 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Philip Tønnesen, M.D.</name_title>
    <organization>Gentofte Hospital</organization>
  </responsible_party>
  <keyword>smoking cessation</keyword>
  <keyword>smokeless tobacco</keyword>
  <keyword>nicotine patch</keyword>
  <keyword>nicotine buccal tablets</keyword>
  <keyword>retreatment</keyword>
  <keyword>adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

